Search research articles
Contact Us
Filters
Showing results (91-100 of 131) with videos related to
Page
of 14
Sort By:
Cancer
|
April 30, 2009
Ductal adenocarcinoma of the prostate: clinical features and implications after local therapy
Shi-Ming Tu, Adriana Lopez, Dan Leibovici, et al.
Plos One
|
March 31, 2015
Association of body composition with outcome of docetaxel chemotherapy in metastatic prostate cancer: a retrospective review
Weixin Wu, Xiandong Liu, Patrick Chaftari, et al.
Cancer
|
January 22, 2009
Long-term outcome for men with teratoma found at postchemotherapy retroperitoneal lymph node dissection
Robert S Svatek, Philippe E Spiess, Debasish Sundi, et al.
Cancer
|
October 24, 2007
Viable germ cell tumor at postchemotherapy retroperitoneal lymph node dissection: can we predict patients at risk of disease progression?
Philippe E Spiess, Nizar M Tannir, Shi-Ming Tu, et al.
Cancer
|
June 24, 2006
Pilot trial of bone-targeted therapy with zoledronate, thalidomide, and interferon-gamma for metastatic renal cell carcinoma
Nizar Tannir, Eric Jonasch, Lance C Pagliaro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 2005
Therapy tolerance in selected patients with androgen-independent prostate cancer following strontium-89 combined with chemotherapy
Shi-Ming Tu, Jeri Kim, Lance C Pagliaro, et al.
Clinical Genitourinary Cancer
|
January 1, 2017
Safety of Same-day Pegfilgrastim Administration in Metastatic Castration-resistant Prostate Cancer Treated With Cabazitaxel With or Without Carboplatin
Mehmet Asim Bilen, Diana H Cauley, Bradley J Atkinson, et al.
Urologic Oncology
|
October 12, 2010
Survival outcomes for men with mediastinal germ-cell tumors: the University of Texas M. D. Anderson Cancer Center experience
Alan J Rodney, Nizar M Tannir, Arlene O Siefker-Radtke, et al.
Cancers
|
March 28, 2024
Stem Cell Origin of Cancer: Clinical Implications beyond Immunotherapy for Drug versus Therapy Development in Cancer Care
Shi-Ming Tu, Anup K Trikannad, Sruthi Vellanki, et al.
The Oncologist
|
January 25, 2021
Pembrolizumab in Patients with Advanced Metastatic Germ Cell Tumors
Apostolia-Maria Tsimberidou, Henry Hiep Vo, Vivek Subbiah, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 131) with videos related to
Sort By:
Page
of 14
Cancer
|
April 30, 2009
Ductal adenocarcinoma of the prostate: clinical features and implications after local therapy
Shi-Ming Tu, Adriana Lopez, Dan Leibovici, et al.
Plos One
|
March 31, 2015
Association of body composition with outcome of docetaxel chemotherapy in metastatic prostate cancer: a retrospective review
Weixin Wu, Xiandong Liu, Patrick Chaftari, et al.
Cancer
|
January 22, 2009
Long-term outcome for men with teratoma found at postchemotherapy retroperitoneal lymph node dissection
Robert S Svatek, Philippe E Spiess, Debasish Sundi, et al.
Cancer
|
October 24, 2007
Viable germ cell tumor at postchemotherapy retroperitoneal lymph node dissection: can we predict patients at risk of disease progression?
Philippe E Spiess, Nizar M Tannir, Shi-Ming Tu, et al.
Cancer
|
June 24, 2006
Pilot trial of bone-targeted therapy with zoledronate, thalidomide, and interferon-gamma for metastatic renal cell carcinoma
Nizar Tannir, Eric Jonasch, Lance C Pagliaro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 2005
Therapy tolerance in selected patients with androgen-independent prostate cancer following strontium-89 combined with chemotherapy
Shi-Ming Tu, Jeri Kim, Lance C Pagliaro, et al.
Clinical Genitourinary Cancer
|
January 1, 2017
Safety of Same-day Pegfilgrastim Administration in Metastatic Castration-resistant Prostate Cancer Treated With Cabazitaxel With or Without Carboplatin
Mehmet Asim Bilen, Diana H Cauley, Bradley J Atkinson, et al.
Urologic Oncology
|
October 12, 2010
Survival outcomes for men with mediastinal germ-cell tumors: the University of Texas M. D. Anderson Cancer Center experience
Alan J Rodney, Nizar M Tannir, Arlene O Siefker-Radtke, et al.
Cancers
|
March 28, 2024
Stem Cell Origin of Cancer: Clinical Implications beyond Immunotherapy for Drug versus Therapy Development in Cancer Care
Shi-Ming Tu, Anup K Trikannad, Sruthi Vellanki, et al.
The Oncologist
|
January 25, 2021
Pembrolizumab in Patients with Advanced Metastatic Germ Cell Tumors
Apostolia-Maria Tsimberidou, Henry Hiep Vo, Vivek Subbiah, et al.
Page
of 14